Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.

Respiratory medicine - 1 Jun 2017

Konno Satoshi, Makita Hironi, Suzuki Masaru, Shimizu Kaoruko, Kimura Hirokazu, Kimura Hiroki, Nishimura Masaharu

Abstract excerpt

BACKGROUND: Acute bronchodilator response (BDR) is a potential phenotypic characteristic of COPD. However, the clinical factors associated with BDR in patients with COPD remain unclear, particularly for BDR to anticholinergic agents. OBJECTIVES: We aimed to clarify the clinical factors associated with BDR to β2-agonist and/or anticholinergic agent, considering time-associated variations of BDR. We also evaluated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenergic beta-2 Receptor Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Albuterol

Share to Bronchodilator Agents

Share to Eosinophils

Share to Forced Expiratory Volume

Share to Pulmonary Disease, Chronic Obstructive

Source

Identifiers

PMID: 28502414
DOI: 10.1016/j.rmed.2017.04.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acute bronchodilator responses to β2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.PMID 28502414Read ↗

Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice.Semantic proximity Read ↗

Beta2-adrenergic receptor polymorphisms as a determinant of preferential bronchodilator responses to β2-agonist and anticholinergic agents in Japanese patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease.Semantic proximity Read ↗

Bronchodilator responsiveness in chronic obstructive pulmonary disease: prevalence, significance, and clinical implications.Semantic proximity Read ↗

Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics.Semantic proximity Read ↗

β2-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam StudySemantic proximity Read ↗

Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response.Semantic proximity Read ↗

The effect of smoking on lung function: a clinical study of adult-onset asthma.Semantic proximity Read ↗

Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.Semantic proximity Read ↗

Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers.Semantic proximity Read ↗

Diversity of respiratory impedance based on quantitative computed tomography in patients with COPD.Semantic proximity Read ↗

Efficacy of anticholinergic drugs in asthma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.